State Street Corporation 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-09 12:01 pm Sale |
2021-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
STATE STREET CORP STT |
84,069 4.810% |
-20,556 (-19.65%) |
Filing |
| 2021-02-11 12:52 pm Purchase |
2020-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
STATE STREET CORP STT |
104,625 6.870% |
104,625 (New Position) |
Filing |